Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy

Fig. 4

Biodistribution of ICG-NPs and ICG-RGD-NPs in mice of liver fibrosis and healthy mice after 24 h a; H&E, Masson and Sirius Red staining of livers collected from healthy and liver fibrotic mice b; collagen I expression of liver tissues from liver fibrotic mice treated with different drug formulations c; quantitative analysis of type I collagen in treated fibrotic livers d. (*p < 0.05, **p < 0.01 and ***p < 0.001 vs Control)

Back to article page